Steven Leibowitz, MD
  • 100 UCLA Medical Plaza, Suite 747, Los Angeles, California,90024
    310-272-0808
  • 653 Town Center Drive, Suite 102, Las Vegas, Nevada,89144
    702-242-5555
  • 8641 Wilshire Blvd, Suite 312, Beverly Hills, California,90211
    310-272-0808
  • 5301 Truxton Avenue, Suite 200, Bakersfield, California,93309
    661-412-2322
  • 299 N. Pecos Road, Henderson, Nevada,89074
    702-242-5555
Procedures

Treatment with Restasis

 

 

What is RESTASIS®?

  • RESTASIS® is the only prescription eye drop that helps increase your eyes’ natural ability to produce tears, which may possibly be reduced by inflammation due to Chronic Dry Eye. RESTASIS® Ophthalmic Emulsion did not increase tear production in patients using topical steroids or tear duct plugs.
  • Research has shown that Chronic Dry Eye (keratoconjunctivitis sicca, sometimes referred to as Dry Eye Syndrome) may possibly be the result of a functional problem in the tear-producing glands of the eyes. This reduces tear production, resulting in an insufficient amount of tears to lubricate or nourish the eye

How does it work?

  • RESTASIS® Ophthalmic Emulsion is the initially prescription eye drop indicated to increase tear production which may possibly be reduced by inflammation on the eye surface in patients with Chronic Dry Eye.
  • RESTASIS® did not increase tear production in patients using topical steroid drops or tear duct plugs.
  • The approved treatment is one drop in the morning and one drop at night in each eye, every day.
  • RESTASIS® Ophthalmic Emulsion helps increase your natural ability to produce tears, which may possibly be reduced by inflammation due to Chronic Dry Eye.
  • RESTASIS® is believed to work on the inflammation to relieve it and enable greater tear production over time.

What are the side effects?

  • The most common side effect reported by 17% of patients was ocular burning. 
  • Other side effects reported by 1% to 5% of patients included conjunctival hyperemia, discharge, epiphora, eye pain, foreign-body sensation, pruritus, stinging, and visual disturbance (most often blurring). 
  • RESTASIS® is contraindicated in patients with active ocular infections and has not been studied in patients with a history of herpes keratitis.

 

Office Locations